The Singapore-based international news channel included Craif in a September 30, 2026 segment on Asian AI startups taking their technology into practical use

TOKYO, October 1, 2026 - CNA, the Singapore-based international news channel, featured Craif Inc. as one of Asia's next-generation AI startups in a segment broadcast on September 30, 2026.

Coverage details

Broadcast date: September 30, 2026

• Outlet: CNA (https://cna.asia)
• Title: "From robots to cancer screenings, Asia's next wave of AI startups is moving into the real world"
• Video: https://youtu.be/PSjJ34el-2g
• Article: https://www.channelnewsasia.com/singapore/nextgen-tech-30-sgx-granite-asia-startups-artificial-intelligence-6421421

About Craif

Craif is a bio-AI company founded in 2018 that develops non-invasive tests for the early detection of cancer. Its platform combines proprietary biomarker detection from urine and other bodily fluids with AI to assess disease risk. Building on one of the world's largest urine datasets, Craif aims to create a urine analysis platform that detects a wide range of diseases early, with cancer as the first step. The company is based in Tokyo and operates a wholly owned laboratory in San Diego, opened in 2026. Learn more at craif.com.

Media inquiries
press_us@craif.com